Ndèye Fatou Ngom Gueye

Author

Centre Hospitalier National Universitaire de Fann

Also Known As

L. Fortes, N F Ngom Gueye, N. F. Ngom Gueye, N.F. Ngom Gueye, N.F. Ngom Guèye, N.F. Ngom Guéye, NDèye Fatou NGom Guèye, Ndeye F. Ngom Gueye, Ndeye Fatou Guèye, Ndeye Fatou Ngom Gueye

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier National Universitaire de Fann Institut de Recherche pour le Développement Université de Montpellier Hôpital Aristide Le Dantec Hôpital Principal de Dakar

About

Ndèye Fatou Ngom Gueye is an author at Centre Hospitalier National Universitaire de Fann specializing in hiv, medicine, and clinical trials.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	107
2	Public Health	2	2	39
3	Global Health	2	2	95
4	Epidemiology	1	1	15
5	Pharmacology	1	1	24

Ndèye Fatou Ngom Gueye

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study Jean-François Étard, Ibrahima Ndiaye, Marion Thierry-Mieg, AIDS	2006	276
The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study Christian Laurent, Ndella Diakhaté, Ndèye Fatou Ngom Gueye, AIDS	2002	271
Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults Christian Laurent, Ndèye Fatou Ngom Gueye, Cheikh Tidiane Ndour, JAIDS Journal of Acquired Immune Deficiency Syndromes	2004	162
High Prevalence of Severe Food Insecurity and Malnutrition among HIV-Infected Adults in Senegal, West Africa Noelle A. Benzekri, Jacques F. Sambou, Binetou Diaw, PLoS ONE	2015	96
Sensitivity of IFN-γ Release Assay to Detect Latent Tuberculosis Infection Is Retained in HIV-Infected Patients but Dependent on HIV/AIDS Progression Farba Karam, Fatou Mbow, Helen A. Fletcher, PLoS ONE	2008	83
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo, The Lancet HIV Lamivudine Dual TherapySuperiority TrialProtease InhibitorTreatment And PreventionGlobal Health	2017	71
Lipodystrophy and Metabolic Disorders in HIV-1-Infected Adults on 4- to 9-Year Antiretroviral Therapy in Senegal: A Case-Control Study S. Mercier, Ndèye Fatou Ngom Gueye, Amandine Cournil, JAIDS Journal of Acquired Immune Deficiency Syndromes	2009	64
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy Laurence Vergne, Coumba Touré Kane, Christian Laurent, AIDS	2003	52
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo, AIDS	2015	41
Primary Prevention With Cotrimoxazole for HIV-1???Infected Adults: Results of the Pilot Study in Dakar, Senegal Maryvonne Maynart, Laurence Li vre, Papa Salif Sow, JAIDS Journal of Acquired Immune Deficiency Syndromes	2001	38

Page 1